Congenital Rubella Syndrome: A Case Report
Ayodhia Pitaloka Pasaribu
1*
,
Munira Ulfa
1
, Syahril Pasaribu
1
, Irma Sari Nasution
1,2
1
Departement of Child Health, Faculty of Medicine, Universitas Sumatera Utara, Adam Malik Hospital,
Jl. Bunga Lau No.17, Medan, Indonesia
2
Faculty of Medicine, Universitas Sumatera Utara, Jl. Dr. T. Mansur No.5, Medan, Sumatera Utara, Indonesia
Keywords: Congenital Rubella Syndrome, virus, infection
Abstract: Congenital rubella syndrome (CRS) is the effect of rubella virus infection during 8-12 weeks of gestation.
In Indonesia, the incidence of CRS annually is 0.2/1000 live newborn. The most common defects of CRS
are hearing defects (deafness), eye defects (cataract, congenital glaucoma), and cardiac defects (PDA). We
reported a case of congenital rubella syndrome in a 5-month-old boy. He was first diagnosed with
congenital rubella syndrome 4 months ago (confirmed by positive of anti-rubella IgM with congenital
cataract and congenital heart disease-PDA and ASD). He was admitted to Adam Malik Hospital due to
congestive heart failure Ross III, bronchopneumonia, marasmus, and anemia. We treated the patient with
bed rest, oxygen supplementation, broad-spectrum empiric antibiotics, antipyretic, diuretic, angiotensin
converting enzyme inhibitor, and nutritional management according to pediatric nutrition.
1 INTRODUCTION
Congenital rubella syndrome (CRS) is an illness in
infants that results from maternal infection with
rubella virus during pregnancy. When rubella
infection occurs during pregnancy, serious
consequences such as miscarriages, stillbirths, and a
constellation of severe birth defects in infants may
happen (Lanzieri, 2012).
In Indonesia, the
incidence of CRS annually is 0.2/1000 live
newborn. Surveillance data of 2015 showed off
979, newly diagnosed CRS case from 4.89 million
live newborns
(Kemenkes RI, 2017).
The natural history of congenital rubella
initiated by maternal viremia presents for several
days before the onset of rash. Maternal viremia may
be followed by placental infection and subsequent
fetal viremia, leading to disseminated infection
involving many fetal organs. Timing is crucial, as
the highly susceptible period of intrauterine rubella
is during the first 8 to 12 weeks (Gershon, 2004).
2 CASE REPORT
A 5-month-old male came to the emergency unit at
Adam Malik Hospital with a chief complaint of
shortness of breath. He had experienced the
symptom since 2 weeks prior to admission,
described as fast breathing and chest indrawing. It
got worsened within two days prior to admission and
aggravated by feeding. One week prior to admission,
the patient was noted to have developed an
intermittent fever. Four weeks prior to admission,
the patient was noted to have an intermittent
productive cough. At that period, he was also noted
to be pale, without a history of bluish discoloration
of skin and lips.
At 2 months old, he had the right eye cataract
surgery. He was then noted to have lost weight
gradually. The highest weight noted was 4000 g at 3
months old. Five months prior to admission, the
patient noted to have interrupted feeding. He was
noted to have fast breathing during feeding, hence
the feeding activity was often interrupted.
On physical examination, his initial body weight
was 3000 gr, body length was 56 cm, and mid-upper
arm circumference was 9 cm. Nutrition status was
marasmus (based on the WHO 2006 Growth chart
weight for length z score, boys age 0-5 years). The
patient was alert but looked ill. The blood pressure
was 75/40 mmHg, heart rate of 160 bpm, respiratory
rate of 62 bpm, and body temperature of 37.5 C
(axilla), peripheral oxygen saturation was 90% at
room air and 96% at oxygen 1 lpm via nasal
cannula.
Pasaribu, A., Ulfa, M., Pasaribu, S. and Nasution, I.
Congenital Rubella Syndrome: A Case Report.
DOI: 10.5220/0009861501110114
In Proceedings of the 2nd International Conference on Tropical Medicine and Infectious Disease (ICTROMI 2019), pages 111-114
ISBN: 978-989-758-469-5
Copyright
c
2020 by SCITEPRESS Science and Technology Publications, Lda. All rights reserved
111
Head circumference was 36.5 cm
(microcephaly), with open flat anterior fontanel, no
old man face, and palpebral conjunctiva was pale
and sclera was anicteric. There was no palpebral
edema. The right pupil was 3 mm and reactive to
light while the left pupil cannot be assessed since it
was covered with whitish discoloration. Abnormal
repetitive, uncontrolled bilateral eye movement from
side to side was noted. There was no nasal flaring
and cyanosis at lips and tongue. No cervical
lymphadenopathy was noted.
He had symmetrical chest expansion, with
intercostal and epigastric retractions, the prominent
appearance of the intercostal area due to thinning of
subcutaneous fat. The respiratory rate was 62 bpm,
regular, coarse rales on both lung fields, with no
wheezing, equal fremitus. Ictus cordis was not
visible and but palpable at IV-V intercostal space on
the left midclavicular line, the thrill was felt. The
heart rate was 160 beats per minute, regular, with
continuous murmur grade 4/6 on the left
infraclavicular area, radiating to the back and the
thrill was palpable.
Abdomen looked globular, soft on palpation,
with normal bowel sound with no palpable liver,
good skin turgor. There was no edema on
extremities, but with muscle hypotrophy and
thinning of subcutaneous fat. The blood pressure
was 70/40 mmHg, peripheral pulses were full and
regular, capillary refill time less than 2 seconds.
There was no abnormality on genitalia and scrotum
examination, both testicles are palpable.
Complete blood count revealed anemia,
leukocytosis, electrolyte imbalance, low serum iron,
normal liver, and kidney function. Blood culture was
drawn, revealed no growth. Chest X-ray revealed
bronchopneumonia and congenital heart disease with
cardiomegaly. Echocardiography revealed secundum
atrial septal defect (ASD) Ø 3.7 mm and PDA Ø 3.9
mm.
The patient was managed with bed rest, oxygen
supplementation, empiric broad-spectrum
antibiotics, antipyretic, diuretic, angiotensin
converting enzyme inhibitor, and nutritional
management according to pediatric nutrition care for
marasmus child.
The admitting diagnosis was congestive heart
failure Ross III due to cyanotic congenital heart
disease (patent ductus arteriosus (PDA) and ASD),
bronchopneumonia, marasmus, anemia, and
congenital rubella syndrome.
Oxygen supplementation 1 lpm was
administered. Antibiotic ampicillin 75 mg/6
hours/IV (25 mg/kg/dose) and gentamycin 15 mg/24
hours/IV (5 mg/kg/day) were started. Paracetamol
40 mg/6 hours (10 mg/kg/dose) per oral was given if
temperature >38°C. Anti-cardiac failure medications
namely furosemide 1x3 mg (1 mg/kgBW/day) and
captopril 2x3.125 mg (1 mg/kgBW/dose) were
continued.
The total caloric requirement was 80-100
kcal/kg/day during the initial phase with a total
calorie of 210 kcal was received, through F75 with
the mineral mix (75 kcal/100 ml) via nasogastric
tube (NGT). The F75 was given in an amount of 35
ml every 3 hours and multivitamins. During the
transitional phase, the total caloric requirement was
100-150 kcal/kg/day, given through oral nutrition
supplement (ONS) with high-calorie infant formula
(100 kcal/100 ml) via NGT-oral. The total volume of
feeding was increased gradually.
Ophthalmology assessment revealed right eye
aphasia and left eye congenital cataract. Subsequent
cataract surgery was suggested when the clinical
condition had been improved. We also planned for a
hearing function test. Unfortunately, the device for
hearing function test was out of order. On growth
and development assessment, we found global
developmental delay.
3 DISCUSSION
In 1941, Norman Gregg, Australian ophthalmologist
has first described a syndrome comprising of
cataracts and congenital heart disease with or
without mental retardation and microcephaly that he
associated with rubella infection in the mothers
during early pregnancy (Mason, 2016). CRS group
classification of clinical signs listed below :
A.
Cataract(s), congenital glaucoma, pigmentary
retinopathy, congenital heart disease (most
commonly peripheral pulmonary artery
stenosis, patent ductus arteriosus or ventricular
septal defects), hearing impairment.
B.
Purpura, splenomegaly, microcephaly,
developmental delay, meningoencephalitis,
radiolucent bone disease, jaundice that begins
within the first 24 hours after birth.
Using these clinical signs, the final
classifications of CRS are as follows: (A) Suspect
CRS: infant less than 12 months of age with at least
one sign from group A; (B) Clinical CRS: infant less
than 12 months of age with at least two signs from
group A; or At least one sign from group A and one
sign from group B without any laboratory
confirmation; (C)
Confirmed CRS: suspect CRS
ICTROMI 2019 - The 2nd International Conference on Tropical Medicine and Infectious Disease
112
with laboratory confirmation shows infant less
than 6 months of age with positive Rubella IgM; (D)
Congenital rubella infection (CRI): infant less than
12 months of age without any clinical signs of CRS,
but who meets the laboratory criteria for CRS
(WHO, 2018 and Ministry of Health Republic of
Indonesia, 2018).
This patient was diagnosed as confirmed CRS,
because he had met the criteria of suspect CRS
(congenital cataract, congenital heart disease-PDA,
and ASD) and laboratory confirmation of positive
anti-rubella IgM when he was 4 months old. Other
important feature like hearing impairment may be
the only manifestation of congenital rubella. It is
probably caused by maldevelopment and
degenerative changes in the cochlea and organ of
Corti. Hearing impairment severity is variable, and
may be overlooked unless detected by an
audiometric examination (Gerson, 2004).
PDA occurs if the ductus arteriosus remains
patent leading to the left-to-right shunt of the heart.
The magnitude of the left-to-right shunt is
determined by the resistance offered by the ductus
(diameter, length, and tortuosity) (Mason, 2016).
Patent ductus arteriosus is also associated with
maternal rubella infection during early pregnancy
(Park, 2014).
The patient has continuous murmur grade 5/6 on
the left infraclavicular area, suggestive of murmur
caused by PDA and had developed retardation of
physical growth due to the shunts. Transcatheter
PDA closure was performed to treat a PDA with a
left-to-right shunt that results in any of the
following: congestive heart failure, failure to thrive,
increased pulmonary blood flow, or an enlarged left
atrium or left ventricle, provided the anatomy and
patient size are suitable (AAP, 2011)
The treatment of CHF consists of elimination of
the underlying causes, treatment of the precipitating
or contributing causes, and control of heart failure
state (Mason, 2016). If the cause of CHF is a
congenital heart defect amenable to surgery, medical
treatment is indicated to prepare the patient for
surgery (Masarone, 2017). The heart failure state is
controlled by the use of multiple drugs, including
inotropic agents, diuretics and afterload-reducing
agent, along with general supportive measures (Park,
2014).
The benefits of a diuretic include the reduction
of systemic, pulmonary, and venous congestion.
Angiotensin-converting enzyme inhibitors decrease
the afterload and possibly reverses the
pathophysiological myocardial remodeling.
Inotropes should be reserved for severe reduction of
cardiac output (Masarone, 2017). In this case, the
patient receives a diuretic (furosemide) and an ACE
inhibitor (captopril). However, the inotropes were
not given since the hemodynamic was stable and
echocardiography revealed good contractility. He
was planned for PDA and ASD transcatheter closure
when he reached a minimum weight of 6 kg.
Respiratory complications are frequent in
children presenting with congenital heart disease.
This group of patients is at a greater risk for viral or
bacterial pulmonary infections. Pongiglione (2016)
stated that in Italy the incidence of respiratory
disease was 63.1%. A total of 26.2% underwent
hospitalization with a median length of hospital stay
was 7 days, and the median age of the patients
hospitalized was <1 year old. The most frequent
respiratory diseases associated with hospitalizations
were lower respiratory tract infections.
This patient experience gradual weight loss when
he was 3 months old, without any data regarding the
length. On admission, he was presented with severe
underweight, severe stunted, diagnosed as
marasmus. The etiology of malnutrition in the
children with CHD can be grouped into the
following three categories: (1) inadequate intake, (2)
inefficient absorption and utilization, and (3)
increased energy needs (Rodica, 2013). Viera (2007)
stated that the caloric intake in hospitalized-children
due to congenital heart disease was 50% below the
recommended daily allowance. Fatigue upon feeding
may explain the decreased intake (Vieira, 2007).
4 CONCLUSION
We have treated a 5-month-old boy who came to
Adam Malik Hospital, Medan, Indonesia due to
shortness of breath. He was diagnosed with
congestive heart failure Ross III due to cyanotic
congenital heart disease (PDA and ASD),
bronchopneumonia, marasmus, anemia, and
congenital rubella syndrome. The patient was treated
with adequate therapy. Congenital rubella syndrome
was confirmed when he was 4 months old, both
laboratory and clinically.
REFERENCES
American Academy of Pediatrics and Society for
Cardiovascular Angiography and Intervention. (2011)
Indications for cardiac catheterization and intervention
in pediatric cardiac disease: A scientific statement
Congenital Rubella Syndrome: A Case Report
113
from the American Heart Association. Circulation. 2011;
123:2607-2652.
Gershon A. Congenital rubella. In: Gershon A, Hotez PJ,
Katz SL, editors. Krugman’s Infectious diseases of
children. 11
th
edition. Pennsylvania: Mosby; 2004.
Kementerian Kesehatan Republik Indonesia. (2017).
Petunjuk teknis kampanye imunisasi measles rubella
(MR). Direktorat jenderal pencegahan dan
pengendalian penyakit Kementerian Kesehatan RI.
Kementerian Kesehatan Republik Indonesia (2018).
Pedoman surveilans congenital rubella syndrome
(CRS). Direktorat surveilans dan karantina kesehatan,
Direktorat pencegahan dan pengendalian penyakit
Kementerian Kesehatan RI.
Lanzieri T, Redd S, Abernathy E, Icenogle J. (2012).
Congenital rubella syndrome. Centers for Disease
Control and Prevention (CDC): Vaccine Preventable
Disease (VPD) Surveillance Manual.
Masarone D, Valente F, Rubino M, Vastarella R, Gravino
R, Rea A, et al. Pediatric heart failure: A practical
guide to diagnosis and management. Pediatrics and
Neonatology. 2017; 58:303-312.
Mason WH. Rubella. In: Kliegman RM, Stanton BF,
Geme III JWS, Schor NF, Behrman RE, editors.
Nelson Textbook of Pediatrics. 20
th
edition.
Philadelphia: Elsevier; 2016. p1337-1341.
Park MK. Pathophysiology of left-to-right shunt lesions.
In: Park’s pediatric cardiology for practitioners. 5
th
edition. Philadelphia: Elsevier; 2014. p124-130.
Pongiglione G, Possidoni A, Paparatti UL, Costanzo AM,
Gualberti G, Bonvicini M, et al. Incidence of
respiratory disease during the first two years of life in
children with hemodynamically significant congenital
heart disease in Italy: A retrospective study. Pediatr
Cardiol. 2016; 37:1581-1589.
Rodica T. Nutritional approach of pediatric patients
diagnosed with congenital heart disease. Acta Medica
Marisiensis. 2013;59(2):121-125.
Vieira TCL, Trigo M, Alonso RR, Ribeiro RHC, Cardoso
MRA, Cordoso ACA, et al. Assessment of food intake
in infants between 0 and 24 months with congenital
heart disease. Arq Bras Cardiol. 2007;89(4):197-202.
World Health Organization. (2018). Congenital rubella
syndrome. Vaccine Preventable Diseases (VPD)
Surveillance Standards.
ICTROMI 2019 - The 2nd International Conference on Tropical Medicine and Infectious Disease
114